Document is current
Any future updates will be listed below
-
Authors
Choate, Kristian A.
Konickson, Wren W. L.
Moreno, Zoe L.
Brill, Olivia S.
Cromell, Brett C.
Detienne, Bella M.
Jennings, Matthew J.
Mann, Paul B.
Winn, Robert J.
Kamson, David O.
Pratt, Evan P.S.
- License Information
-
More Information
Article History
Received: 20 November 2024
Accepted: 6 March 2025
First Online: 14 March 2025
Declarations
:
: Deidentified glioma tumor samples with known IDH1-R132 mutational status were provided by Advocate Aurora Research Institute, LLC, Milwaukee, WI (Aurora IRB# 14–79). For human urine and serum collection in this study, informed consent to participate was obtained from all three donors. The Institutional Review Board at Northern Michigan University waived the requirement for approval to conduct human subjects research. This study adhered to the ethical principles outlined in the Declaration of Helsinki.
: Not applicable.
: E.P.S.P. and M.J.J. hold a provisional patent on D2HGlo. There are no conflicts of interest to declare for K.A.C., W.W.L.K., Z.L.M., O.S.B., B.C.C., B.M.D., P.B.M., R.J.W. and D.O.K.
